Hoppa till huvudinnehåll

Clopidogrel resistance

Clopidogrel resistance is a condition in which the drug clopidogrel is less effective than normal in people who are treated with it. Clopidogrel (also known as Plavix) is an antiplatelet drug, which means that it prevents blood cells called platelets from sticking together (aggregating) and forming blood clots. This drug is typically given to prevent blood clot formation in individuals with a history of stroke; heart attack; a blood clot in the deep veins of the arms or legs (deep vein thrombosis); or plaque buildup (atherosclerosis) in the blood vessels leading from the heart, which are opened by placement of a small thin tube (stent).

Beskrivning

Clopidogrel resistance is a condition in which the drug clopidogrel is less effective than normal in people who are treated with it. Clopidogrel (also known as Plavix) is an antiplatelet drug, which means that it prevents blood cells called platelets from sticking together (aggregating) and forming blood clots. This drug is typically given to prevent blood clot formation in individuals with a history of stroke; heart attack; a blood clot in the deep veins of the arms or legs (deep vein thrombosis); or plaque buildup (atherosclerosis) in the blood vessels leading from the heart, which are opened by placement of a small thin tube (stent).

People with clopidogrel resistance who receive clopidogrel are at risk of serious, sometimes fatal, complications. These individuals may have another heart attack or stroke caused by abnormal blood clot formation; those with stents can develop blood clots (thromboses) within the stents, impeding blood flow.

People with clopidogrel resistance can be divided into two categories: intermediate metabolizers and poor metabolizers. Intermediate metabolizers are able to process some clopidogrel, so they receive partial benefit from the treatment but are not protected from developing a harmful blood clot. Poor metabolizers process little or no clopidogrel, so they receive very limited benefit from the treatment and are at risk of forming a harmful blood clot.

Clopidogrel resistance does not appear to cause any health problems other than those associated with clopidogrel drug treatment.

Inheritance patterns

The source lists the following possible inheritance patterns: Autosomal codominant. More than one pattern can apply in different cases.

Other names

CYP2C19-related poor drug metabolism

Poor metabolism of clopidogrel

Resistance to clopidogrel

Related patient information and medicines

Antifosfolipidsyndrom

Patient information leaflet

Antifosfolipidsyndrom

Antiphospholipid syndrome is sometimes called Hughes' syndrome. Antiphospholipid syndrome (APS) - also called Hughes' syndrome - makes blood more likely than normal to clot (a thrombophilia Thrombophilia ). Clopidogrel Clopidogrel till prevent blodet clots , dipyridamole Dipyridamole to prevent blood clots and aspirin Aspirin to prevent blood clots.

Hjärtsjukdom

Patient information leaflet

Hjärtsjukdom

Treatments include the following: Medication Medicines are used to: Thin the blood and prevent blood clots forming in the heart and elsewhere in the body (eg, aspirin, clopidogrel, warfarin, apixaban) Improve blood flow to the heart (eg, nicorandil, ranolazine, ramipril) Slow down the heart rate if it is beating too fast (eg, bisoprolol,.

Brutna eller blåslagna revben

Patient information leaflet

Brutna eller blåslagna revben

You have a history of heart disease, stroke or peripheral ar... You have asthma, high blood pressure, kidney disease or may be pregnant. You are already taking aspirin (including low-dose aspirin Aspirin to prevent blood clots ) or clopidogrel Clopidogrel to prevent blood clots. You are taking these painkillers for long periods - say, for over two.

Transitorisk ischemisk attack

Patient information leaflet

Transitorisk ischemisk attack

A transient ischaemic attack (TIA) causes symptoms similar to a stroke. The most commonly used long-term antiplatelet medicine following a stroke or TIA is clopidogrel Clopidogrel to prevent blood clots. Sometimes, once a TIA or minor stroke has been diagnosed, people are offered a short course of two antiplatelet medications together (aspirin and.

Perifer artärsjukdom

Patient information leaflet

Perifer artärsjukdom

Peripheral arterial disease, also called peripheral vascular disease, is a narrowing of the blood vessels (arteries). Surgery is only needed in ... Medicines A medicine called clopidogrel Clopidogrel to prevent blood clots is usually advised. This does not help with symptoms of PAD but helps to prevent blood clots (thromboses) forming in blood.

Aspirin och andra blodförtunnande läkemedel

Patient information leaflet

Aspirin och andra blodförtunnande läkemedel

Most people who have a cardiovascular disease (for example, angina, peripheral arterial disease, or a previous heart attack, transient ischaemic attack (TIA) or stroke) take a low-dose aspirin (75 mg) each day or clopidogrel (75 mg) each day. For those with peripheral arterial disease (damage to the arteries in the legs), clopi... After a stroke.

Vidare läsning och referenser

Artikelhistorik

Informationen på denna sida är skriven och granskad av kvalificerade kliniker.
  • 24 nov 2023 | Senaste versionen
  • 1 Dec 2015 | Ursprungligen publicerad

Delta i konversationen

Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.

Ansvarsfriskrivning: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Onlineapotek, behandlingar och hälsotjänster

Enkel tillgång till pålitliga behandlingar och hälsotjänster online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Anmäl dig till Patientens nyhetsbrev

Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.

Vänligen ange en giltig e-postadress

Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.